Stratasys Ltd Stock Price, News & Analysis

MakerBot, a Stratasys company (NASDAQ: SSYS), has introduced two innovative products: RapidRinse fast-dissolving support material and ABS-R polymer for enhanced 3D printing. Designed for the MakerBot METHOD X® and Carbon Fiber 3D printers, these materials simplify the 3D printing process with ABS, reducing workflow steps and costs. RapidRinse dissolves in warm tap water without harmful chemicals, streamlining post-processing. The ABS-R formulation enhances printing reliability. Both products are expected to ship in December 2021.

Stratasys Ltd. (NASDAQ: SSYS) will hold its 2021 Annual General Meeting on November 23, 2021, in Israel. Shareholders eligible to vote must be on record by October 15, 2021. Key agenda items include the re-election of directors, an increase of 1,300,000 shares for the Omnibus Equity Incentive Plan, and the adoption of an Employee Share Purchase Plan with 5,200,000 shares. Approval of the updated Compensation Policy is also on the agenda. Kesselman & Kesselman will be reappointed as independent auditors. A majority vote is required for proposal approvals.

Stratasys (NASDAQ: SSYS) has acquired all remaining shares of Xaar 3D Ltd. from Xaar plc, enhancing its position in production-scale 3D printing. Previously owning a 45% stake, Stratasys aims to leverage Xaar 3D’s SAF technology to boost manufacturing capabilities. The Stratasys H350™ 3D printer, the first powered by this technology, promises cost-competitive production with improved part consistency. The acquisition is expected to facilitate development and widen market outreach.

Stratasys has launched ProtectAM, a cybersecurity solution aimed at enhancing data security for additive manufacturing, particularly in government and defense applications. Utilizing Red Hat Enterprise Linux, ProtectAM ensures compliance with the U.S. Department of Defense's security standards. Initially available for select Stratasys printers, like the Fortus 450mc, it is set to expand to other models by early 2022. This initiative aims to support rapid production of critical parts while safeguarding sensitive information.

MakerBot, a Stratasys company (NASDAQ: SSYS), released its 2nd annual report on 3D printing in education. The findings indicate that 3D printing significantly enhances student engagement and collaboration, even in remote learning environments. Based on over 1,000 responses from educators globally, 57% utilized 3D printing for student-designed projects, while 36% incorporated it into lesson plans. However, 40% reported lack of equipment access as a barrier. The report underscores the importance of creative problem-solving skills and highlights educators' anticipation for more resources in the upcoming school year.

Stratasys Ltd. (NASDAQ: SSYS) has expanded its healthcare services by launching a Healthcare Print Center in Eden Prairie, Minn., utilizing J750 Digital Anatomy printers. This facility enables the production of realistic 3D printed anatomical models for medical device manufacturers and healthcare providers. In just 13 weeks, Stratasys Direct has printed over 1,000 models for top medical device manufacturers, running each machine for over 120 hours weekly. Additionally, they provide comprehensive design and consulting services tailored to meet client needs.

Stratasys Ltd. (NASDAQ: SSYS) showcased advancements in additive manufacturing at the RAPID + TCT Show, emphasizing new materials and software partnerships. The company introduced new polymer 3D printing systems targeting mass production and launched the Origin Open Material License for enhanced material customization. With expanded material options like High-Yield PA11 and Dura56, Stratasys aims to enhance manufacturing efficiency. The GrabCAD Software Partner Program also expanded, integrating new partners to streamline production workflows in compliance with Industry 4.0.

Stratasys Ltd. (NASDAQ: SSYS) reported strong second-quarter 2021 results with revenue reaching $147.0 million, a 25% increase from the previous year. GAAP gross margin improved to 43.0%, up from 37.2%. Operating losses decreased, with a GAAP loss of $22.7 million compared to $29.3 million last year. Non-GAAP net loss narrowed to $1.6 million, or $0.02 per diluted share. Adjusted EBITDA was $3.5 million, reflecting positive operational cash flow. The company anticipates 17% - 18% revenue growth in Q3 2021, emphasizing expansion in healthcare and manufacturing.